share_log
Reuters ·  Mar 20 20:07

Mar 20 (Reuters) - Terns Pharmaceuticals Q4 Operating Expenses USD 25.949 Million.

  • Q4 Basic EPS USD -0.24
  • Q4 Income From Operations USD -25.949 Million
  • Q4 Pretax Profit USD -21.759 Million
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 314

Recommended

Write a comment